Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.
Hay
C R
CR
Department of Haematology, University of Liverpool, Royal Liverpool University Hospital, UK.
Lozier
J N
JN
Lee
C A
CA
Lafan
M
M
Tradati
H
H
Santagostino
E
E
Ciavarella
N
N
Schiavoni
M
M
Fukui
H
H
Yoshioka
A
A
D000818:Animals; D003429:Cross Reactions; D005169:Factor VIII / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000601:surgery; D006801:Humans; D007262:Infusions, Intravenous; D018579:Patient Selection; D010976:Platelet Count / Q000187:drug effects; D013552:Swine
D005169:Factor VIII